Company intelligence / Profile preview

Hambro Perks

London, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Hambro Perks, now Salica Investments, is an active investor in over 100 firms, including several in biotech and healthcare. The firm itself does not conduct clinical trials or develop therapeutic products.

Industry: Investors

Partnerships

ISSF (Innovative Startups and SMEs Fund, for HP Oryx Fund in MENA)

Beyond the preview

Go deeper on Hambro Perks.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hambro Perks.

Explore the full profile